From the 2022 Joint Annual
Meeting (recorded 6/29/2022)
Presented by Carlo
Ledesma, MS, MLS(ASCP)CM,SHCM, QLSCM, DLMCM,
MT(AMT)
Clinical decisions contributing
to positive patient outcomes are guided, in part, by clinical laboratory
results. However, ambiguity and lack of consensus in standardizing laboratory
results for transgender patients are significantly missing in clinical
laboratory medicine. This session will outline current scientific evidence and
standards of care in relation to transgender health and discuss the role of
clinical laboratories in promoting positive patient outcomes for transgender
patients and those who are in gender-affirming therapies.
LEARNING OBJECTIVES
At the conclusion of this presentation,
participants will be able to:
- Define sexual orientation, gender identity and gender dysphoria.
- Summarize the standards of care relevant to transgender health.
- Facilitate a patient-centered, gender-inclusive laboratory practice.
CE ACCREDITATION
ASCLS is approved as a provider of continuing
education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ®
Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the
area of GEN (General) will be awarded to
participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of
Certification and all states, including Florida and California, as an approved
provider of continuing education for recertification and licensure. ASCLS is an
approved provider with CE Broker for Florida licensees.
LEVEL OF INSTRUCTION
This Intermediate-level
program is appropriate for laboratory professionals working in clinical, public
health and academic settings.